Interestingly, the transcriptome analysis of human benign tumors, where the presence of senescent cells is assumed, did not consistently show a decrease in the ANT2 transcript levels across all analyzed types, except for colon adenomas. This evidence concerns the gene SLC25A5 and benign neoplasm.